MeSH D014353 - african trypanosomiasis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D000079426:Vector borne diseases
0 Companies
0 Drugs
Success rate
D014352:Trypanosomiasis
0 Companies
0 Drugs
Success rate
D014353:
African trypanosomiasis
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| AbbVie | Eflornithine | Vaniqa | 2000-07-27 | |||
| Almirall | Eflornithine | Vaniqa | 2001-03-19 | |||
| Sanofi | Fexinidazole | Fexinidazole | 2021-07-16 | |||
| Eflornithine | Ornidyl | 1990-11-28 |
Clinical Trials
Historical Success Rate
Phase 1
100%2/2
Phase 2
67%4/6
Phase 3
71%5/7
Approved: 2Overall Success rate: 48%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use